Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
6.28
+0.41 (6.98%)
At close: Dec 5, 2025, 4:00 PM EST
6.16
-0.12 (-1.91%)
After-hours: Dec 5, 2025, 5:01 PM EST
Eupraxia Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 12.41 | 10.92 | 7.48 | 3.99 | 6.48 | 1 | |
| Research & Development | 17.35 | 16.08 | 20.36 | 13.63 | 7.58 | 0.67 | |
| Operating Expenses | 29.75 | 27 | 27.85 | 17.62 | 14.15 | 1.76 | |
| Operating Income | -29.75 | -27 | -27.85 | -17.62 | -14.15 | -1.76 | |
| Interest Expense | -0.36 | -0.96 | -1.17 | -0.98 | -0.97 | -1.48 | |
| Interest & Investment Income | 0.96 | 1.16 | 0.86 | 0.43 | 0.05 | 0 | |
| Currency Exchange Gain (Loss) | -0.27 | -0.16 | 0.07 | 0.24 | 0.16 | 0.1 | |
| Other Non Operating Income (Expenses) | - | 1.2 | -0.84 | -1.06 | -4.74 | 0.1 | |
| EBT Excluding Unusual Items | -29.41 | -25.76 | -28.92 | -18.98 | -19.65 | -3.04 | |
| Gain (Loss) on Sale of Assets | 0.01 | 0.02 | -0 | -0.01 | - | -0.1 | |
| Other Unusual Items | - | - | - | - | 0.42 | - | |
| Pretax Income | -29.41 | -25.74 | -28.93 | -18.99 | -19.23 | -3.15 | |
| Income Tax Expense | 0.01 | 0 | 0.04 | - | - | - | |
| Earnings From Continuing Operations | -29.42 | -25.74 | -28.97 | -18.99 | -19.23 | -3.15 | |
| Minority Interest in Earnings | 0.04 | 0.24 | 0.75 | 0.5 | 0.3 | 0.01 | |
| Net Income | -29.37 | -25.5 | -28.22 | -18.49 | -18.93 | -3.14 | |
| Preferred Dividends & Other Adjustments | 2.34 | 0.43 | - | - | - | - | |
| Net Income to Common | -31.71 | -25.93 | -28.22 | -18.49 | -18.93 | -3.14 | |
| Shares Outstanding (Basic) | 36 | 34 | 24 | 19 | 12 | 6 | |
| Shares Outstanding (Diluted) | 36 | 34 | 24 | 19 | 12 | 6 | |
| Shares Change (YoY) | 13.17% | 40.52% | 25.21% | 55.45% | 102.75% | 0.01% | |
| EPS (Basic) | -0.88 | -0.76 | -1.17 | -0.96 | -1.53 | -0.51 | |
| EPS (Diluted) | -0.88 | -0.76 | -1.17 | -0.96 | -1.53 | -0.51 | |
| Free Cash Flow | -25.24 | -30.1 | -20.82 | -14.63 | -12.06 | -0.32 | |
| Free Cash Flow Per Share | -0.70 | -0.89 | -0.86 | -0.76 | -0.97 | -0.05 | |
| EBITDA | -29.6 | -26.89 | -27.73 | -17.51 | -14.11 | -1.73 | |
| D&A For EBITDA | 0.15 | 0.11 | 0.11 | 0.11 | 0.04 | 0.03 | |
| EBIT | -29.75 | -27 | -27.85 | -17.62 | -14.15 | -1.76 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.